Gene · 5449
Papers2,504
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,504
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deep Learning Based on Magnetic Resonance Imaging for Preoperative Prediction of Pituitary Neuroendocrine Tumors Subtypes. | Acad Radiol | 2026 | 42736093 | PubTator, text mining | PubMed |
| Case Report: Development of a thyrotropinoma in a patient with thyroid hemiagenesis. | Front Endocrinol (Lausanne) | 2026 | 42723820 | PubTator, text mining | PubMed |
| What do you mean by PitNETs in WHO Classification 2022? | Endocr J | 2026 | 42702553 | PubTator, text mining | PubMed |
| Differential expression of cyclin D1 in pituitary neuroendocrine tumours: Relation to aggressive potential. | Afr J Lab Med | 2026 | 42699363 | PubTator, text mining | PubMed |
| Radiomics and artificial intelligence in pituitary adenomas (PitNETs): from imaging biomarkers to clinical translation. | Rev Endocr Metab Disord | 2026 | 42684588 | PubTator, text mining | PubMed |
| Multiparametric MRI-Based Ensemble Deep Learning for Preoperative Classification of Pituitary Neuroendocrine Tumor Subtypes. | Acad Radiol | 2026 | 42680659 | PubTator, text mining | PubMed |
| Cushing disease caused by a TBX19/PIT1 co-expressing pituitary adenoma/pituitary neuroendocrine tumor. | J Neuropathol Exp Neurol | 2026 | 42658565 | PubTator, text mining | PubMed |
Integrin αvβ6 Expression in the Human Pituitary Gland and Pituitary Neuroendocrine Tumors: Immunohistochemical Characterization with Potential Relevance to αvβ6 PET/CT Pituitary Uptake and Theranostic Implications. | Biomolecules | 2026 | 42650848 | PubTator, text mining | PubMed |
| Comparative analysis of SCGN expression patterns in the anterior pituitary gland of mouse, pig, and human by single-cell transcriptomics. | J Neuroendocrinol | 2026 | 42633787 | PubTator, text mining | PubMed |
| Sellar region neurocytomas exhibit a CIMP and neuroendocrine-like epigenetic signature distinct from other intra-axial neurocytomas. | Acta Neuropathol | 2026 | 42611353 | PubTator, text mining | PubMed |
| Acidophil stem cell-like pituitary neuroendocrine tumors with heterogeneous PIT1/SF1 or LH lineage-marker expression: a clinicopathological study of three cases. | Front Endocrinol (Lausanne) | 2026 | 42563988 | PubTator, text mining | PubMed |
| Invasiveness, SOX2 Expression, and Resection Outcomes in TF-Defined PitNETs After Extra-Pseudocapsular Resection. | Curr Med Sci | 2026 | 42545569 | PubTator, text mining | PubMed |
| Aggressive pituitary neuroendocrine tumours display a distinct immune microenvironment. | J Clin Endocrinol Metab | 2026 | 42530027 | PubTator, text mining | PubMed |
| Efficacy of long-acting growth hormone in Axenfeld-Rieger syndrome with a novel 3.824 Mb 4q25 deletion: a Case Report and systematic literature review. | Front Genet | 2026 | 42382124 | PubTator, text mining | PubMed |
| Immune and clinicopathological features of molecularly defined prolactinoma subtypes. | J Neurosurg | 2026 | 42361377 | PubTator, text mining | PubMed |
| Pathological Classification and Clinical Characteristics of Growth Hormone-Secreting PitNETs. | Neuroendocrinology | 2026 | 42348504 | PubTator, text mining | PubMed |
| CD8+ T Lymphocytes in Pituitary Neuroendocrine Tumors: Friend or Foe? | Cells | 2026 | 42346142 | PubTator, text mining | PubMed |
| Lineage-specific steroidomic signatures in pituitary neuroendocrine tumors: pregnenolone enrichment in SF-1 lineage and associations with tumor behavior. | Endocr Relat Cancer | 2026 | 42333631 | PubTator, text mining | PubMed |
| Phosphate homeostasis and endocrine regulators. | Pediatr Nephrol | 2026 | 42322396 | PubTator, text mining | PubMed |
| Combination therapy of pasireotide and pegvisomant for aggressive acromegaly with an immature PIT1-lineage PitNET. | Endocrinol Diabetes Metab Case Rep | 2026 | 42314763 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5449/papers